• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钾钙通道3.1(KCa 3.1)的表观遗传失调导致肺癌预后不良。

Epigenetic dysregulation of KCa 3.1 channels induces poor prognosis in lung cancer.

作者信息

Bulk Etmar, Ay Anne-Sophie, Hammadi Mehdi, Ouadid-Ahidouch Halima, Schelhaas Sonja, Hascher Antje, Rohde Christian, Thoennissen Nils H, Wiewrodt Rainer, Schmidt Eva, Marra Alessandro, Hillejan Ludger, Jacobs Andreas H, Klein Hans-Ulrich, Dugas Martin, Berdel Wolfgang E, Müller-Tidow Carsten, Schwab Albrecht

机构信息

Institute of Physiology II, University of Münster, Münster, Germany.

Laboratory of Cellular Physiology, EA 4667, SFR CAP-SANTE (FED4231), UFR Sciences, University of Picardie Jules Verne, Amiens, 80039, France.

出版信息

Int J Cancer. 2015 Sep 15;137(6):1306-17. doi: 10.1002/ijc.29490. Epub 2015 May 29.

DOI:10.1002/ijc.29490
PMID:25704182
Abstract

Epigenomic changes are an important feature of malignant tumors. How tumor aggressiveness is affected by DNA methylation of specific loci is largely unexplored. In genome-wide DNA methylation analyses, we identified the KCa 3.1 channel gene (KCNN4) promoter to be hypomethylated in an aggressive non-small-cell lung carcinoma (NSCLC) cell line and in patient samples. Accordingly, KCa 3.1 expression was increased in more aggressive NSCLC cells. Both findings were strong predictors for poor prognosis in lung adenocarcinoma. Increased KCa 3.1 expression was associated with aggressive features of NSCLC cells. Proliferation and migration of pro-metastatic NSCLC cells depended on KCa 3.1 activity. Mechanistically, elevated KCa 3.1 expression hyperpolarized the membrane potential, thereby augmenting the driving force for Ca(2+) influx. KCa 3.1 blockade strongly reduced the growth of xenografted NSCLC cells in mice as measured by positron emission tomography-computed tomography. Thus, loss of DNA methylation of the KCNN4 promoter and increased KCa 3.1 channel expression and function are mechanistically linked to poor survival of NSCLC patients.

摘要

表观基因组变化是恶性肿瘤的一个重要特征。特定基因座的DNA甲基化如何影响肿瘤侵袭性在很大程度上尚未得到探索。在全基因组DNA甲基化分析中,我们发现钾钙激活通道蛋白3.1(KCa 3.1)通道基因(KCNN4)启动子在一种侵袭性非小细胞肺癌(NSCLC)细胞系和患者样本中存在低甲基化。相应地,在侵袭性更强的NSCLC细胞中KCa 3.1表达增加。这两个发现都是肺腺癌预后不良的有力预测指标。KCa 3.1表达增加与NSCLC细胞的侵袭性特征相关。促转移NSCLC细胞的增殖和迁移依赖于KCa 3.1活性。从机制上讲,KCa 3.1表达升高使膜电位超极化,从而增强了钙离子内流的驱动力。通过正电子发射断层扫描-计算机断层扫描测量,KCa 3.1阻断显著降低了小鼠体内异种移植NSCLC细胞的生长。因此,KCNN4启动子的DNA甲基化缺失以及KCa 3.1通道表达和功能增加在机制上与NSCLC患者的不良生存相关。

相似文献

1
Epigenetic dysregulation of KCa 3.1 channels induces poor prognosis in lung cancer.钾钙通道3.1(KCa 3.1)的表观遗传失调导致肺癌预后不良。
Int J Cancer. 2015 Sep 15;137(6):1306-17. doi: 10.1002/ijc.29490. Epub 2015 May 29.
2
Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.非小细胞肺癌中因启动子甲基化导致肺及食管发育不全相关基因 1 频繁的表观遗传失活。
Clin Lung Cancer. 2010 Jul 1;11(4):264-70. doi: 10.3816/CLC.2010.n.034.
3
Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.对非小细胞肺癌异种移植物的表观基因组分析揭示了 LRP12 DNA 甲基化作为卡铂耐药的预测性生物标志物。
Genome Med. 2018 Jul 20;10(1):55. doi: 10.1186/s13073-018-0562-1.
4
Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.ITIH5在肺腺癌中的低表达与患者的不良预后相关。
Epigenetics. 2015;10(10):903-12. doi: 10.1080/15592294.2015.1078049. Epub 2015 Aug 7.
5
KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling.KDM2A 通过表观遗传增强 ERK1/2 信号促进肺肿瘤发生。
J Clin Invest. 2013 Dec;123(12):5231-46. doi: 10.1172/JCI68642. Epub 2013 Nov 8.
6
The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer.EPHB6 受体酪氨酸激酶是一种转移抑制因子,在非小细胞肺癌中常因启动子 DNA 高甲基化而失活。
Clin Cancer Res. 2010 Apr 15;16(8):2275-83. doi: 10.1158/1078-0432.CCR-09-2000. Epub 2010 Apr 6.
7
An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.肺癌的综合表观基因组-转录组图谱揭示了具有诊断和治疗意义的新型甲基化驱动基因。
Theranostics. 2021 Mar 11;11(11):5346-5364. doi: 10.7150/thno.58385. eCollection 2021.
8
Determination of O⁶-methylguanine DNA methyltransferase promoter methylation in non-small cell lung cancer.非小细胞肺癌中O⁶-甲基鸟嘌呤DNA甲基转移酶启动子甲基化的测定
Genet Test Mol Biomarkers. 2011 May;15(5):357-60. doi: 10.1089/gtmb.2010.0211. Epub 2011 Feb 2.
9
Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.β-连环蛋白启动子甲基化介导的沉默增强非小细胞肺癌的侵袭性并预示不良预后。
PLoS One. 2014 Nov 14;9(11):e112258. doi: 10.1371/journal.pone.0112258. eCollection 2014.
10
Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.非小细胞肺癌中 TGFβ 假受体 BAMBI 的下调增强 TGFβ 信号转导和侵袭。
Cancer Res. 2016 Jul 1;76(13):3785-801. doi: 10.1158/0008-5472.CAN-15-1326. Epub 2016 May 17.

引用本文的文献

1
Fluorescent Probes to Image the K3.1 Channel in Tumor Cells.用于对肿瘤细胞中的K3.1通道进行成像的荧光探针。
Pharmaceutics. 2025 Jan 23;17(2):154. doi: 10.3390/pharmaceutics17020154.
2
Potassium KCa3.1 channel overexpression deteriorates functionality and availability of channels at the outer cellular membrane.钾离子KCa3.1通道的过表达会使细胞膜外通道的功能和可用性恶化。
Sci Rep. 2025 Feb 10;15(1):4928. doi: 10.1038/s41598-025-89097-8.
3
A comprehensive investigation of PRMT5 in the prognosis and ion channel features of lung cancer.
PRMT5在肺癌预后及离子通道特征方面的综合研究。
Front Oncol. 2024 Nov 29;14:1478672. doi: 10.3389/fonc.2024.1478672. eCollection 2024.
4
Intracellular acidity impedes KCa3.1 activation by Riluzole and SKA-31.细胞内酸性环境会阻碍利鲁唑和SKA - 31对KCa3.1的激活作用。
Front Pharmacol. 2024 Apr 4;15:1380655. doi: 10.3389/fphar.2024.1380655. eCollection 2024.
5
Targeting K3.1 channels to overcome erlotinib resistance in non-small cell lung cancer cells.靶向K3.1通道以克服非小细胞肺癌细胞中的厄洛替尼耐药性。
Cell Death Discov. 2024 Jan 4;10(1):2. doi: 10.1038/s41420-023-01776-5.
6
IK Channel-Independent Effects of Clotrimazole and Senicapoc on Cancer Cells Viability and Migration.克霉唑和银杏酸对癌细胞活力和迁移的 IK 通道非依赖性影响。
Int J Mol Sci. 2023 Nov 14;24(22):16285. doi: 10.3390/ijms242216285.
7
Overexpression of KCNN4 channels in principal neurons produces an anti-seizure effect without reducing their coding ability.在主要神经元中KCNN4通道的过表达产生抗癫痫作用而不降低其编码能力。
Gene Ther. 2024 Mar;31(3-4):144-153. doi: 10.1038/s41434-023-00427-9. Epub 2023 Nov 15.
8
Ion channels in lung cancer: biological and clinical relevance.肺癌中的离子通道:生物学及临床意义
Front Pharmacol. 2023 Oct 24;14:1283623. doi: 10.3389/fphar.2023.1283623. eCollection 2023.
9
Potassium channels as novel molecular targets in hepatocellular carcinoma (Review).钾通道作为肝细胞癌的新型分子靶点(综述)。
Oncol Rep. 2023 Oct;50(4). doi: 10.3892/or.2023.8622. Epub 2023 Sep 1.
10
Ion Channels as Potential Tools for the Diagnosis, Prognosis, and Treatment of HPV-Associated Cancers.离子通道作为 HPV 相关癌症的诊断、预后和治疗的潜在工具。
Cells. 2023 May 12;12(10):1376. doi: 10.3390/cells12101376.